Retinol-binding protein (RBP), which mediates retinol transport in blood plasma, and STRA6, which is an RA receptor and translocator across the plasma membrane, are proposed as potent protooncogenes and key players in cancer stem cell maintenance [53,54]. The gene discussed is STRA6; the disease is cancer.